Document Detail

Treatment of obsessive homosexual pedophilic fantasies with medroxyprogesterone acetate.
MedLine Citation:
PMID:  667234     Owner:  NLM     Status:  MEDLINE    
The author describes a male patient with obsessive homosexual pedophilic fantasies treated with psychotherapy and medroxyprogesterone acetate (MPA), a progestin with antiandrogen activity. Long-acting MPA was administered for a 2-month period and caused a prompt and drastic reduction in fantasies and in the anxiety and depression generated by them. MPA was observed to have psychological benefits that outlived its physiologic activity.
E R Pinta
Related Documents :
6672944 - Adjusting proportional mortality ratios for the influence of extraneous causes of death.
16644514 - Bilateral congenital dacryocystocoeles with concurrent intranasal mucocoeles causing re...
6937824 - A retrospective cohort study of mortality among stainless steel welders.
22470234 - Periodontitis: a risk for delivery of premature labor and low birth weight infants.
11755034 - Oligosaccharides: application in infant food.
17052944 - Sudden death due to tuberculosis.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Biological psychiatry     Volume:  13     ISSN:  0006-3223     ISO Abbreviation:  Biol. Psychiatry     Publication Date:  1978 Jun 
Date Detail:
Created Date:  1978-09-29     Completed Date:  1978-09-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0213264     Medline TA:  Biol Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  369-73     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Medroxyprogesterone / administration & dosage,  analogs & derivatives*
Paraphilias / drug therapy*
Pedophilia / drug therapy*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Circadian rhythm disorders in manic-depressives.
Next Document:  CSF acid monoamine metabolites in psychotic syndromes: what might they signify?